HIGHLIGHTS
- who: Anouchka Plan Sangnier and colleagues from the CNRS and University Diderot, France, Sorbonne have published the Article: Hybrid Au, in the Journal: (JOURNAL) of 06/08/2018
SUMMARY
Findings Bisphosphonates (BPs) are used in the treatment of a variety of bone diseases, such as osteoporosis, solid tumor bone metastases and myeloma bone disease. BPs contain two phosphonate groups linked by a common carbon atom (P-C-P) binding divalent metal ions (Ca2+, Mg2+, and Fe2+) by coordi- nation of the two phosphonate groups. Abdelkarim, M.; Guenin, E.; Sainte-Catherine, O.; Vintonenko, N . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.